A Medical Device Daily
ev3(Plymouth Minnesota) has been awarded three, three-year contracts by Novation, (Irving, Texas) the healthcare contracting and services company of VHA and the University HealthSystem Consortium (UHC, Oakbrook, Illinois), two national healthcare alliances. Beginning Oct. 1, the nearly 2,500 hospital members and affiliates of VHA and UHC will have access to ev3's portfolio of peripheral vascular and neurovascular products through Novation's peripheral interventional, thrombus management and neuro interventional contracts.
The largest healthcare contracting services company in the U.S., Novation represents $31.6 billion in annual purchasing volume, 49% of the nation's hospital admissions, 90% of U.S. academic centers and 52% of the nation's surgeries. About $523 million of Novation's purchasing volume comes from the peripheral interventional, thrombus management and neuro interventional portfolios.
"ev3 is proud to be recognized by Novation as a partner capable of delivering a broad product line to its membership," said Jim Corbett, president/CEO of ev3. "Our inclusion in these contracts is a significant validation of our emerging leadership position in the peripheral and neurovascular markets."
These contract awards follow Novation's signing of a single-source, new technology agreement for ev3's Onyx liquid embolic system, reported by ev3 March 1.
ev3 is focused on endovascular technologies for the minimally invasive treatment of vascular diseases and disorders.